×
About 18,365 results

ALLMedicine™ Vitamin K Center

Research & Reviews  8,587 results

No Vitamin K Antagonists for Patients with Abdominal Aortic Aneurysms or Peripheral Art...
https://doi.org/10.1016/j.ejvs.2021.04.007
European Journal of Vascular and endoVascular Surgery : T... Dosluoglu HH

May 17th, 2021 - No Vitamin K Antagonists for Patients with Abdominal Aortic Aneurysms or Peripheral Arterial Disease? Are We There yet?|2021|Dosluoglu HH,|

Costs of minor bleeds in atrial fibrillation patients using a non-vitamin K antagonist ...
https://doi.org/10.1080/03007995.2021.1929893
Current Medical Research and Opinion; Mitrovic D, Plomp M et. al.

May 14th, 2021 - A very common side effect of non-vitamin K antagonist oral anticoagulant (NOAC) is (minor) bleeding. Data about impact and costs of minor bleeds in NOAC therapy is still limited or not present in current literature. In this patient orientated stud...

Therapeutic quality control in a regional thrombosis center: The effect of changing the...
https://doi.org/10.1016/j.thromres.2021.04.024
Thrombosis Research; Van't Land RP, Banga JD et. al.

May 14th, 2021 - The target ranges (TR) for anticoagulation with vitamin K antagonists (VKA) in the Netherlands were changed in 2016 from INR 2.0-3.5 ('low intensity') and INR 2.5-4.0 ('high intensity') to INR 2.0-3.0 and INR 2.5-3.5, respectively. To assess the e...

The anti-osteoporosis effects of Vitamin K in postmenopausal women.
https://doi.org/10.2174/1574888X16666210512020103
Current Stem Cell Research & Therapy; Liu Y, He Y et. al.

May 13th, 2021 - As a common systemically muscular-skeleton disorder in aging, osteoporosis is characterized by the uninterrupted deconstruction in osseous microarchitecture. Osteoporosis can consequently lead to a significantly high risk of osteoporotic fractures...

Characterization of dynamic changes in Matrix Gla Protein (MGP) gene expression as func...
https://doi.org/10.1016/j.joca.2021.05.001
Osteoarthritis and Cartilage; Houtman E, de Almeida RC et. al.

May 13th, 2021 - We here aimed to characterize changes of Matrix Gla Protein (MGP) expression in relation to its recently identified OA risk allele rs1800801-T in OA cartilage, subchondral bone and human ex vivo osteochondral explants subjected to OA related stimu...

see more →

Guidelines  55 results

Anticoagulation: Updated Guidelines for Outpatient Management
https://www.aafp.org/afp/2019/1001/p426.html
American Family Physician;

Sep 30th, 2019 - Anticoagulation therapy is recommended for preventing, treating, and reducing the recurrence of venous thromboembolism, and preventing stroke in persons with atrial fibrillation. Direct oral anticoagulants are first-line agents for eligible patien...

Association Among Dietary Supplement Use, Nutrient Intake, and Mortality Among U.S. Adults
https://annals.org/aim/article-abstract/2730525/association-among-dietary-supplement-use-nutrient-intake-mortality-among-u
Chen,F.,et al

Apr 8th, 2019 - Background: The health benefits and risks of dietary supplement use are controversial. Objective: To evaluate the association among dietary supplement use, levels of nutrient intake from foods and supplements, and mortality among U.S. adults. De...

2018 Focused Update of the Canadian Cardiovascular Society Guidelines for the Managemen...
https://doi.org/10.1016/j.cjca.2018.08.026
The Canadian Journal of Cardiology; Andrade JG, Verma A et. al.

Nov 8th, 2018 - The Canadian Cardiovascular Society (CCS) Atrial Fibrillation Guidelines Committee provides periodic reviews of new data to produce focused updates that address clinically important advances in atrial fibrillation (AF) management. This 2018 Focuse...

THE USE OF VITAMINS AND MINERALS IN SKELETAL HEALTH: AMERICAN ASSOCIATION OF CLINICAL E...
https://doi.org/10.4158/PS-2018-0050
Endocrine Practice : Official Journal of the American Col... Hurley DL, Binkley N et. al.

Jul 23rd, 2018 - 25(OH)D = 25-hydroxyvitamin D; BMD = bone mineral density; CV = cardiovascular; GI = gastrointestinal; IOM = Institute of Medicine; PTH = parathyroid hormone; RCT = randomized controlled trial; αTF = α-tocopherol; ucOC = undercarboxylated osteocal...

State of play and future direction with NOACs: An expert consensus.
https://doi.org/10.1016/j.vph.2018.04.001
Vascular Pharmacology; Cohen AT, Lip GY et. al.

Apr 15th, 2018 - Atrial fibrillation (AF) and venous thromboembolism (VTE) are cardiovascular conditions significant in contemporary practice. In both, the use of anticoagulation with vitamin K antagonists (VKAs) has been traditionally used to prevent adverse even...

see more →

Drugs  105 results see all →

Clinicaltrials.gov  9,095 results

No Vitamin K Antagonists for Patients with Abdominal Aortic Aneurysms or Peripheral Art...
https://doi.org/10.1016/j.ejvs.2021.04.007
European Journal of Vascular and endoVascular Surgery : T... Dosluoglu HH

May 17th, 2021 - No Vitamin K Antagonists for Patients with Abdominal Aortic Aneurysms or Peripheral Arterial Disease? Are We There yet?|2021|Dosluoglu HH,|

Costs of minor bleeds in atrial fibrillation patients using a non-vitamin K antagonist ...
https://doi.org/10.1080/03007995.2021.1929893
Current Medical Research and Opinion; Mitrovic D, Plomp M et. al.

May 14th, 2021 - A very common side effect of non-vitamin K antagonist oral anticoagulant (NOAC) is (minor) bleeding. Data about impact and costs of minor bleeds in NOAC therapy is still limited or not present in current literature. In this patient orientated stud...

Therapeutic quality control in a regional thrombosis center: The effect of changing the...
https://doi.org/10.1016/j.thromres.2021.04.024
Thrombosis Research; Van't Land RP, Banga JD et. al.

May 14th, 2021 - The target ranges (TR) for anticoagulation with vitamin K antagonists (VKA) in the Netherlands were changed in 2016 from INR 2.0-3.5 ('low intensity') and INR 2.5-4.0 ('high intensity') to INR 2.0-3.0 and INR 2.5-3.5, respectively. To assess the e...

The anti-osteoporosis effects of Vitamin K in postmenopausal women.
https://doi.org/10.2174/1574888X16666210512020103
Current Stem Cell Research & Therapy; Liu Y, He Y et. al.

May 13th, 2021 - As a common systemically muscular-skeleton disorder in aging, osteoporosis is characterized by the uninterrupted deconstruction in osseous microarchitecture. Osteoporosis can consequently lead to a significantly high risk of osteoporotic fractures...

Characterization of dynamic changes in Matrix Gla Protein (MGP) gene expression as func...
https://doi.org/10.1016/j.joca.2021.05.001
Osteoarthritis and Cartilage; Houtman E, de Almeida RC et. al.

May 13th, 2021 - We here aimed to characterize changes of Matrix Gla Protein (MGP) expression in relation to its recently identified OA risk allele rs1800801-T in OA cartilage, subchondral bone and human ex vivo osteochondral explants subjected to OA related stimu...

see more →

News  519 results

New ASH Guidelines: VTE Prevention and Treatment in Cancer Patients
https://www.medscape.com/viewarticle/946777

Mar 2nd, 2021 - New guidelines from the American Society of Hematology "strongly recommend" using no thromboprophylaxis over using parenteral thromboprophylaxis in ambulatory patients receiving cancer chemotherapy who have low venous thromboembolism (VTE) risk, a...

DOACs Look Safe in Elective Endoscopic Procedures
https://www.medscape.com/viewarticle/943566

Jan 4th, 2021 - Among patients taking direct oral anticoagulants (DOACs), elective endoscopy procedures carry a risk of bleeding and thromboembolic events similar to that seen in those receiving vitamin K antagonists (VKAs), according to a multicenter, prospectiv...

INR Correction in VKA-related Major Bleeding Linked to Better Survival
https://www.medscape.com/viewarticle/941681

Nov 26th, 2020 - Takeaway Uncorrected international normalised ratio (INR) is an important risk factor for mortality in vitamin K antagonist (VKA)-associated major bleeding for both intracranial haemorrhage (ICH) and non-ICH patients. Higher doses of vitamin K are...

Warfarin Use Linked to Knee and Hip Replacement in Osteoarthritis Patients
https://www.staging.medscape.com/viewarticle/940569

Nov 7th, 2020 - Patients who take the vitamin K antagonist warfarin to prevent thromboembolic events are significantly more likely to require knee or hip replacement surgery — a surrogate endpoint for end-stage osteoarthritis — than are patients who take direct o...

Warfarin Use Linked to Knee and Hip Replacement in Osteoarthritis Patients
https://www.medscape.com/viewarticle/940569

Nov 7th, 2020 - Patients who take the vitamin K antagonist warfarin to prevent thromboembolic events are significantly more likely to require knee or hip replacement surgery — a surrogate endpoint for end-stage osteoarthritis — than are patients who take direct o...

see more →

Patient Education  4 results see all →